- Home
- PLBY vs NVCT Comparison
PLBY vs NVCT Comparison
Compare PLBY & NVCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLBY
- NVCT
- Stock Information
- Founded
- PLBY 1953
- NVCT 2020
- Country
- PLBY United States
- NVCT United States
- Employees
- PLBY N/A
- NVCT N/A
- Industry
- PLBY Recreational Games/Products/Toys
- NVCT Medicinal Chemicals and Botanical Products
- Sector
- PLBY Consumer Discretionary
- NVCT Health Care
- Exchange
- PLBY Nasdaq
- NVCT Nasdaq
- Market Cap
- PLBY 187.1M
- NVCT 167.0M
- IPO Year
- PLBY N/A
- NVCT 2022
- Fundamental
- Price
- PLBY $1.60
- NVCT $6.19
- Analyst Decision
- PLBY Strong Buy
- NVCT Strong Buy
- Analyst Count
- PLBY 1
- NVCT 3
- Target Price
- PLBY $3.00
- NVCT $15.33
- AVG Volume (30 Days)
- PLBY 342.5K
- NVCT 60.0K
- Earning Date
- PLBY 11-11-2025
- NVCT 11-04-2025
- Dividend Yield
- PLBY N/A
- NVCT N/A
- EPS Growth
- PLBY N/A
- NVCT N/A
- EPS
- PLBY N/A
- NVCT N/A
- Revenue
- PLBY $119,954,000.00
- NVCT N/A
- Revenue This Year
- PLBY $6.32
- NVCT N/A
- Revenue Next Year
- PLBY $3.49
- NVCT N/A
- P/E Ratio
- PLBY N/A
- NVCT N/A
- Revenue Growth
- PLBY N/A
- NVCT N/A
- 52 Week Low
- PLBY $0.66
- NVCT $4.44
- 52 Week High
- PLBY $2.44
- NVCT $11.80
- Technical
- Relative Strength Index (RSI)
- PLBY 43.47
- NVCT 42.49
- Support Level
- PLBY $1.52
- NVCT $6.15
- Resistance Level
- PLBY $1.84
- NVCT $6.61
- Average True Range (ATR)
- PLBY 0.10
- NVCT 0.27
- MACD
- PLBY -0.01
- NVCT 0.01
- Stochastic Oscillator
- PLBY 18.60
- NVCT 5.48
About PLBY PLBY Group Inc.
Playboy Inc, formerly PLBY Group Inc connects consumers around the world with products, services, and experiences to help them look good, feel good, and have fun. PLBY Group serves consumers in four categories: Style and Apparel, Digital Entertainment and Lifestyle, Sexual Wellness, and Beauty and Grooming. It operates through three segments Direct-to-Consumer, Licensing, and Digital Subscriptions and Content. It generates revenue through the sales of products and content services to consumers.
About NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.